01Clear / amber
Ampoule
0Mampoules p.a.
Type I glass, flame-sealed. No closure, no elastomer, nothing to fail at the interface.
- Fill
- 1–10 ml
- Lines
- Operational
Eluru, AP · Operational
SAANSO PHARMA CDMO
Working for a healthier world.
Made as if a life depends on it.
Sterile injectables, BFS and inhalation anaesthetics engineered to Schedule M, U.S. FDA and EU GMP standards.
60M+Units / year
4 FormatsSingle Site
WHO-GMPCompliant
Eluru, Andhra Pradesh
Working for a healthier world.
Made as if a life depends on it.
Sterile injectables, BFS and inhalation anaesthetics engineered to Schedule M, U.S. FDA and EU GMP standards.
WHO WE ARE
Named after oxygen — the breath that sustains us.
Healthcare becomes meaningful when it reaches the person who needs it. That simple idea has shaped Saanso since 2017.
Our MissionMaking high-quality generic medicines and inhalers accessible without high price barriers.
Our FacilityBuilt in Eluru, Andhra Pradesh with state-of-the-art sterile manufacturing.
Quality shouldn't be a privilege. It should be the standard.
OUR SCALE OF CARE
Sterile & specialty CDMO
Four formats. One facility.
First in South India to have a unified facility equipped with five specialised production lines. One site, one team, one audit, four routes to market — none of it subcontracted.
0M
Units a year, all formats
02Liquid + lyo
Vial
0Mvials p.a.
Liquid and lyophilised. Stoppered under nitrogen, capped and inspected in line.
- Fill
- 2–100 ml
- Lines
- Operational
03LDPE amps / vials
Blow-Fill-Seal
0Mvials p.a.
Formed, filled and sealed in one cycle. The container does not exist before the product goes in.
- Fill
- 0.5–500 ml
- Lines
- Operational
04Segregated flow
Volatile Anaesthetics
0Mbottles p.a.
Halogenated ethers in solvent-compatible lines, with agent-specific fillers and closures.
- Fill
- 100 / 250 ml
- Lines
- Operational
The pairing almost nobody has
Sterile injectables and inhalation anaesthetics. One block, two flows.
Volatile anaesthetics are not a sterile dosage form, so most sterile manufacturers never take them on. We run both in one block, separated by protocol rather than by postcode: distinct personnel entry and exit routes, distinct raw material and finished goods routes, and product-contact parts that never cross between them.
- PDE / toxicological assessment
- Air handling and pressure cascade
- Campaign changeover
- Cleaning validation
Full flow diagrams and the risk assessment are available under NDA.
Halogenated agents
- SevofluranePending
- IsofluranePending
- DesfluranePending
- HalothanePending
Colours follow the international agent-identification code used on vaporisers and packaging.
For a customer, that takes a supplier off the list: a theatre-suite portfolio consolidates to one site, one audit, one relationship.
Quality assurance
- Sterile by design
- Washing, depyrogenation, automated fill-seal and autoclaving — a sterile chain with no manual break in it.
- Tested, then tested again
- In-house microbiology and QC across wet chemistry and instrumentation, to written protocol.
- Documented end to end
- Qualification, validation and QMS maintained for audit, batch by batch.
01
02
03
Product portfolio
What we make, and what is coming.
In market today, manufactured and released from Eluru.
3 categories · 30 products
Insights & News
Research, updates & clinical notes.
Discover our latest research documents, conference keynotes, and clinical division launches.
Industry··12 min read
The lifecycle of a drug: from concept to consumer
Discovery to approval to the surveillance that begins the day a medicine reaches a real patient.
Read Article
Industry··10 min read
Optimizing the pharmaceutical supply chain for efficiency
COVID exposed how brittle pharma logistics were. IoT tracking, cold chain and robotics are what replaced the assumptions.
Read Article
Industry··9 min read
5 key factors driving pharmaceutical industry growth in 2025
AI, gene therapy, an ageing population and virtual trials — the genuine shifts, not the press releases.
Read Article